Company Filing History:
Years Active: 1984-1987
Title: Michael Kloft: Innovator in Pharmaceutical Compositions
Introduction
Michael Kloft is a notable inventor based in Darmstadt-Arheilgen, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compositions for treating ulcers. With a total of 3 patents to his name, Kloft's work has had a meaningful impact on medical science.
Latest Patents
Kloft's latest patents focus on pharmaceutical compositions that utilize 2-Aryltetraazaindenes. These compositions are designed to treat ulcers and exhibit various beneficial activities, including blood pressure regulation and myocardial contraction. The specific formulations include 2-Aryltetraazaindenes of the formula where --A-- is --N.dbd.CH--CN.dbd.N-- or --CH.dbd.N--N.dbd.CH--, and Ar is an unsubstituted phenyl or phenyl that is mono-, di-, or tri-substituted by various functional groups. These innovative compositions demonstrate promising therapeutic effects and their physiologically acceptable salts.
Career Highlights
Michael Kloft is associated with Merck Patent Gesellschaft mit beschränkter Haftung, a prominent company in the pharmaceutical industry. His work at Merck has allowed him to focus on groundbreaking research and development in the field of drug formulations.
Collaborations
Kloft has collaborated with notable colleagues such as Rochus Jonas and Hanns Wurziger. These partnerships have contributed to the advancement of his research and the successful development of his patented compositions.
Conclusion
Michael Kloft's contributions to pharmaceutical innovations, particularly in ulcer treatment, highlight his role as a significant inventor in the field. His patents reflect a commitment to improving medical therapies and enhancing patient care.